中东欧及中亚地区宫颈癌预防建议。 - Suppr

Recommendations for cervical cancer prevention in Central and Eastern Europe and Central Asia.

作者信息

Poljak Mario, Rogovskaya Svetlana I, Kesić Vesna, Bray Freddie, Berkhof Johannes, Seme Katja, Brotons Maria, Castellsagué Xavier, Syrjänen Stina, Arbyn Marc, Bosch F Xavier

机构信息

Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.

Department of Obstetrics and Gynecology, Russian Medical Academy of Post-Graduate Education, Moscow, Russia.

出版信息

Vaccine. 2013 Dec 31;31 Suppl 7:H80-2. doi: 10.1016/j.vaccine.2013.04.038.

DOI:10.1016/j.vaccine.2013.04.038

PMID:24332300

Abstract

摘要

相似文献

Recommendations for cervical cancer prevention in Central and Eastern Europe and Central Asia.

Vaccine. 2013 Dec 31;31 Suppl 7:H80-2. doi: 10.1016/j.vaccine.2013.04.038.

Prevention of cervical cancer in Central and Eastern Europe and Central Asia: a challenge for the future.

Vaccine. 2013 Dec 31;31 Suppl 7:vii-ix. doi: 10.1016/j.vaccine.2012.11.105.

Cost-effectiveness of cervical cancer prevention in Central and Eastern Europe and Central Asia.

Vaccine. 2013 Dec 31;31 Suppl 7:H71-9. doi: 10.1016/j.vaccine.2013.04.086.

Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.

Vaccine. 2013 Dec 31;31 Suppl 7:H46-58. doi: 10.1016/j.vaccine.2013.06.043.

Screening for cervical cancer and human papillomavirus vaccination in Israel: recommendations.

Vaccine. 2013 Nov 22;31 Suppl 8:I58-60. doi: 10.1016/j.vaccine.2013.07.048.

Patterns and trends in human papillomavirus-related diseases in Central and Eastern Europe and Central Asia.

Vaccine. 2013 Dec 31;31 Suppl 7:H32-45. doi: 10.1016/j.vaccine.2013.02.071.

Trials and projects on cervical cancer and human papillomavirus prevention in sub-Saharan Africa.

Vaccine. 2013 Dec 29;31 Suppl 5:F53-9. doi: 10.1016/j.vaccine.2012.06.070.

[Gynecologic cancer--prevention strategy of cervical neoplasms with vaccine].

Gan To Kagaku Ryoho. 2010 Feb;37(2):221.

[Prevention of cervical cancer. Screening and vaccination: methods of use].

Gynecol Obstet Fertil. 2011 Jul-Aug;39(7-8):405-6. doi: 10.1016/j.gyobfe.2011.05.003. Epub 2011 Jul 14.

European consensus statement on "HPV Vaccination and Colposcopy".

J Low Genit Tract Dis. 2011 Oct;15(4):309-15. doi: 10.1097/LGT.0b013e318222b2c4.

引用本文的文献

Impact of SARS-CoV-2 Pandemic on the Diagnosis of Cervical Cancer and Precursor Lesions-A Single-Center Retrospective Study.

Medicina (Kaunas). 2024 May 30;60(6):909. doi: 10.3390/medicina60060909.

Health and economic effects of introducing single-dose or two-dose human papillomavirus vaccination in India.

BMJ Glob Health. 2023 Nov;8(11). doi: 10.1136/bmjgh-2023-012580.

Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative.

Lancet Glob Health. 2023 Feb;11(2):e197-e206. doi: 10.1016/S2214-109X(22)00501-0. Epub 2022 Dec 14.

Interstitial collagenase MMP-1 and EMMPRIN in cell lines and in clinical specimens of cervical squamous cell carcinoma.

Mol Biol Rep. 2021 Oct;48(10):6879-6886. doi: 10.1007/s11033-021-06689-z. Epub 2021 Sep 8.

The Contribution of the European School Of Oncology Education to the Central Asian and Caucasian Regions.

J Cancer Educ. 2022 Feb;37(1):224-229. doi: 10.1007/s13187-021-02072-5. Epub 2021 Jul 22.

Preventable fractions of cervical cancer via effective screening in six Baltic, central, and eastern European countries 2017-40: a population-based study.

Lancet Oncol. 2016 Oct;17(10):1445-1452. doi: 10.1016/S1470-2045(16)30275-3. Epub 2016 Aug 23.

The Knowledge of the Role of Papillomavirus-Related Head and Neck Pathologies among General Practitioners, Otolaryngologists and Trainees. A Survey-Based Study.

PLoS One. 2015 Oct 26;10(10):e0141003. doi: 10.1371/journal.pone.0141003. eCollection 2015.

HPV-FASTER: broadening the scope for prevention of HPV-related cancer.

Nat Rev Clin Oncol. 2016 Feb;13(2):119-32. doi: 10.1038/nrclinonc.2015.146. Epub 2015 Sep 1.

Potential coverage of circulating HPV types by current and developing vaccines in a group of women in Bosnia and Herzegovina with abnormal Pap smears.

Epidemiol Infect. 2015 Sep;143(12):2604-12. doi: 10.1017/S0950268814003720. Epub 2015 Jan 12.

E-cadherin expression and prognosis of oral cancer: a meta-analysis.

Tumour Biol. 2014 Jun;35(6):5533-7. doi: 10.1007/s13277-014-1728-0. Epub 2014 Feb 27.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Recommendations for cervical cancer prevention in Central and Eastern Europe and Central Asia.

作者信息

Poljak Mario, Rogovskaya Svetlana I, Kesić Vesna, Bray Freddie, Berkhof Johannes, Seme Katja, Brotons Maria, Castellsagué Xavier, Syrjänen Stina, Arbyn Marc, Bosch F Xavier

机构信息

Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.

Department of Obstetrics and Gynecology, Russian Medical Academy of Post-Graduate Education, Moscow, Russia.

出版信息

Vaccine. 2013 Dec 31;31 Suppl 7:H80-2. doi: 10.1016/j.vaccine.2013.04.038.

DOI:10.1016/j.vaccine.2013.04.038

PMID:24332300

Abstract

摘要

相似文献

Recommendations for cervical cancer prevention in Central and Eastern Europe and Central Asia.

Vaccine. 2013 Dec 31;31 Suppl 7:H80-2. doi: 10.1016/j.vaccine.2013.04.038.

Prevention of cervical cancer in Central and Eastern Europe and Central Asia: a challenge for the future.

Vaccine. 2013 Dec 31;31 Suppl 7:vii-ix. doi: 10.1016/j.vaccine.2012.11.105.

Cost-effectiveness of cervical cancer prevention in Central and Eastern Europe and Central Asia.

Vaccine. 2013 Dec 31;31 Suppl 7:H71-9. doi: 10.1016/j.vaccine.2013.04.086.

Vaccine. 2013 Dec 31;31 Suppl 7:H46-58. doi: 10.1016/j.vaccine.2013.06.043.

Screening for cervical cancer and human papillomavirus vaccination in Israel: recommendations.

Vaccine. 2013 Nov 22;31 Suppl 8:I58-60. doi: 10.1016/j.vaccine.2013.07.048.

Patterns and trends in human papillomavirus-related diseases in Central and Eastern Europe and Central Asia.

Vaccine. 2013 Dec 31;31 Suppl 7:H32-45. doi: 10.1016/j.vaccine.2013.02.071.

Trials and projects on cervical cancer and human papillomavirus prevention in sub-Saharan Africa.

Vaccine. 2013 Dec 29;31 Suppl 5:F53-9. doi: 10.1016/j.vaccine.2012.06.070.

[Gynecologic cancer--prevention strategy of cervical neoplasms with vaccine].

Gan To Kagaku Ryoho. 2010 Feb;37(2):221.

[Prevention of cervical cancer. Screening and vaccination: methods of use].

Gynecol Obstet Fertil. 2011 Jul-Aug;39(7-8):405-6. doi: 10.1016/j.gyobfe.2011.05.003. Epub 2011 Jul 14.

European consensus statement on "HPV Vaccination and Colposcopy".

J Low Genit Tract Dis. 2011 Oct;15(4):309-15. doi: 10.1097/LGT.0b013e318222b2c4.

引用本文的文献

Impact of SARS-CoV-2 Pandemic on the Diagnosis of Cervical Cancer and Precursor Lesions-A Single-Center Retrospective Study.

Medicina (Kaunas). 2024 May 30;60(6):909. doi: 10.3390/medicina60060909.

Health and economic effects of introducing single-dose or two-dose human papillomavirus vaccination in India.

BMJ Glob Health. 2023 Nov;8(11). doi: 10.1136/bmjgh-2023-012580.

Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative.

Lancet Glob Health. 2023 Feb;11(2):e197-e206. doi: 10.1016/S2214-109X(22)00501-0. Epub 2022 Dec 14.

Interstitial collagenase MMP-1 and EMMPRIN in cell lines and in clinical specimens of cervical squamous cell carcinoma.

Mol Biol Rep. 2021 Oct;48(10):6879-6886. doi: 10.1007/s11033-021-06689-z. Epub 2021 Sep 8.

The Contribution of the European School Of Oncology Education to the Central Asian and Caucasian Regions.

J Cancer Educ. 2022 Feb;37(1):224-229. doi: 10.1007/s13187-021-02072-5. Epub 2021 Jul 22.

Preventable fractions of cervical cancer via effective screening in six Baltic, central, and eastern European countries 2017-40: a population-based study.

Lancet Oncol. 2016 Oct;17(10):1445-1452. doi: 10.1016/S1470-2045(16)30275-3. Epub 2016 Aug 23.

The Knowledge of the Role of Papillomavirus-Related Head and Neck Pathologies among General Practitioners, Otolaryngologists and Trainees. A Survey-Based Study.

PLoS One. 2015 Oct 26;10(10):e0141003. doi: 10.1371/journal.pone.0141003. eCollection 2015.

HPV-FASTER: broadening the scope for prevention of HPV-related cancer.

Nat Rev Clin Oncol. 2016 Feb;13(2):119-32. doi: 10.1038/nrclinonc.2015.146. Epub 2015 Sep 1.

Potential coverage of circulating HPV types by current and developing vaccines in a group of women in Bosnia and Herzegovina with abnormal Pap smears.

Epidemiol Infect. 2015 Sep;143(12):2604-12. doi: 10.1017/S0950268814003720. Epub 2015 Jan 12.

E-cadherin expression and prognosis of oral cancer: a meta-analysis.

Tumour Biol. 2014 Jun;35(6):5533-7. doi: 10.1007/s13277-014-1728-0. Epub 2014 Feb 27.

Recommendations for cervical cancer prevention in Central and Eastern Europe and Central Asia.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Recommendations for cervical cancer prevention in Central and Eastern Europe and Central Asia.

作者信息

机构信息

出版信息

相似文献

引用本文的文献